The National Association of Boards of Pharmacy has reinstated the North American Pharmacist Licensure Exam at all the Prometric testing centers.
NABP is once again offering the North American Pharmacist Licensure Exam (NAPLEX) after a two-month layoff. In August, NABP temporarily
FDA Approves Lebrikizumab-lbkz for Moderate-to-Severe Atopic Dermatitis
September 16th 2024Lebrikizumab-lbks is a targeted treatment that addresses the root cause of atopic dermatitis; by reducing inflammation throughout the body, it can help alleviate the dry, itchy, and irritated skin that often characterizes the condition.